Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 22 resources
-
Eliminating Hepatitis C in Scotland: A Call to Action
The Hepatitis C Trust, following an inquiry held with the cross-party Scottish Hepatitis C Parliamentary Champions group, published a report, 'Eliminating Hepatitis C in Scotland: A Call to Action'. The report looks in detail at Scotland's approach to hepatitis C, focusing on the need for an elimination strategy, awareness, prevention, testing & diagnosis, linkage to care, access to treatment and funding. The report also features a series of recommendations for action to boost Scotland's progress towards achieving elimination.UK, Scotland Reports & Research, Strategy & Planning PDF -
Needle Exchange Surveillance Initiative: 2008-9 to 2015-16
The Needle Exchange Surveillance Initiative measures and monitorings the prevalence of blood-borne viruses and injecting risk behaviours among people who inject drugs in Scotland. This report presents the results, at the NHS board level, for the data collection period from February 2015 until March 2016. It also presents the findings of the NESI survey, at Scotland-wide level, from 2008-09 until the most recent survey, 2015-16.UK, Scotland Mar 2017 Reports & Research PDF -
National Clinical Guidelines for the treatment of HCV in adults
These Scottish guidelines, updated in January 2016, provide expert guidance to Health Boards, Area Drug and Therapeutics Committees, and treating clinicians on the efficacy of available treatments for hepatitis C. They also act as a clinical reference source for NHS National Procurement to produce rankings on cost-effectiveness. Development of the guidance was a collaboration between Scotland's viral hepatitis clinical leads and MCN co-ordinators network, National Services Scotland, and Healthcare Improvement Scotland.Scotland Jan 2017 Other, Strategy & Planning PDF -
Penrose Inquiry Recommendation: Report of a Scottish Government Commissioned Short Life Working Group
In light of the Penrose Inquiry recommendation, the Scottish Government recommended that a Short-Life Working Group, involving key stakeholders including those from the Scottish Government and the Scottish National Blood Transfusion Service, be established by Health Protection Scotland. This is the group's final report, which includes a number of key recommendations, including the delivery of a national awareness campaign.Scotland Sep 2016 Reports & Research PDF -
HCV Action good practice case study: Waverley Care Self Management Programme
This good practice case study looks at the Waverley Care Self Management Programme. The programme involves the delivery of workshops to people with hepatitis C, which focus on issues such as self-identity, confidence, self-esteem, goal setting and problem solving, with the aim of supporting people with hepatitis C to make informed choices regarding their lifestyle choices and improve the knowledge that they have of their condition.
The case study explains details why the programme was established, how it works, and the outcomes that it has achieved.UK, Scotland Apr 2016 Case study PDF -
HCV Action good practice case study: Positive Help support services
This good practice case study looks at the support services offered to people with hepatitis C in the Lothians by Positive Help. These services include a transport service which allows service users to attend appointments and stay engaged in the care pathway, as well as a service providing domestic help in service users' homes.
This case study details why the services were established, how they work, and the outcomes that they have achieved.UK, Scotland Apr 2016 Case study PDF -
Scottish National Clinical Guidelines for the treatment of HCV in adults
These guidelines, published by Health Improvement Scotland and NHS National Services Scotland, provide guidance to Health Board Area Drug and Therapeutics Committees on the recommended use of available hepatitis C drugs, taking into consideration Scottish Medicines Consortium guidance, clinical effectiveness and price.UK, Scotland Feb 2016 Other, Strategy & Planning PDF -
HCV Action good practice case study: Developing patient-centred care in Inverclyde and Renfrewshire
Inverclyde, in west central Scotland, has the highest estimated prevalence of problem drug use in Scotland (3.2% compared to a national average of 1.58%), while neighbouring Renfrewshire has the fourth highest in Scotland (2.41%). Both areas (which have above-average rates of deprivation) also have high hepatitis C prevalence rates, with many of those with the virus unaware of it.UK, Scotland Nov 2015 Case study PDF -
Shooting Up: Infections among people who inject drugs in the UK 2014 - An update, November 2015
This annual national report describes trends in the extent of infections and associated risks and behaviours among people who inject drugs in the UK to the end of 2014. Among its findings are that:
- Two in five of those people in the UK who inject psychoactive drugs are living with hepatitis C, with around half of these infections remaining undiagnosed.
- Changing patterns of psychoactive drug injection are increasing the risk of infection.UK, England, Northern Ireland, Scotland, Wales Nov 2015 Reports & Research PDF -
National Clinical Guidelines for the treatment of HCV in adults
These guidelines provide expert guidance to Health Boards, Area Drug and Therapeutics Committees, and treating clinicians on the efficacy of available treatments for hepatitis C. They also act as a clinical reference source for NHS National Procurement to produce rankings on cost-effectiveness.
Development of the guidance was a collaboration between Scotland's viral hepatitis clinical leads and MCN co-ordinators network, National Services Scotland, and Healthcare Improvement Scotland.Scotland Sep 2015 Other, Strategy & Planning PDF